Eton Pharmaceuticals (ETON) Non Operating Income (2019 - 2025)
Eton Pharmaceuticals (ETON) reported Non Operating Income of -$1.0 million for Q4 2025, up 7.89% on a YoY basis from -$973170.7 in Q4 2024, and down 77.36% sequentially from -$592000.0 in Q3 2025.
Eton Pharmaceuticals (ETON) Non Operating Income (2019 - 2025) Analysis & Trends
Eton Pharmaceuticals (ETON) has 7 years of Non Operating Income data on file, last reported at -$1.0 million in Q4 2025.
- For the quarter ending Q4 2025, Non Operating Income rose 7.89% year-over-year to -$1.0 million; the trailing twelve-month figure through Dec 2025 stood at -$3.7 million (down 206.69% YoY), and the FY2025 full-year result was -$3.7 million, down 206.69% from the prior year.
- Non Operating Income retreated to -$1.0 million in Q4 2025, from -$592000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $784000.0 in Q4 2023 to a low of -$1.1 million in Q4 2024.
- A 5-year average of -$269450.0 and a median of -$227500.0 in 2021 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income surged 622.67% in 2023 and tumbled 9245.45% in 2025, its largest moves.
- Tracing ETON's Non Operating Income over 5 years: stood at -$275000.0 in 2021, then jumped by 45.45% to -$150000.0 in 2022, then surged by 622.67% to $784000.0 in 2023, then plunged by 245.41% to -$1.1 million in 2024, then advanced by 7.89% to -$1.0 million in 2025.
- Business Quant data shows ETON's Non Operating Income at -$1.0 million in Q4 2025, -$592000.0 in Q3 2025, and -$1.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -216.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 20.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -7.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 53.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Eton Pharmaceuticals | 1.19 Bn | 1.16 Bn | 13.10 Mn | -1.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.05 Mn |
| Sep 30, 2025 | -592,000.00 |
| Jun 30, 2025 | -1.04 Mn |
| Mar 31, 2025 | -1.03 Mn |
| Dec 31, 2024 | -1.14 Mn |
| Sep 30, 2024 | -8,000.00 |
| Jun 30, 2024 | -52,000.00 |
| Mar 31, 2024 | -11,000.00 |
| Dec 31, 2023 | 784,000.00 |
| Sep 30, 2023 | -31,000.00 |
| Jun 30, 2023 | 676,000.00 |
| Mar 31, 2023 | -126,000.00 |
| Dec 31, 2022 | -150,000.00 |
| Sep 30, 2022 | -150,000.00 |
| Jun 30, 2022 | -218,000.00 |
| Mar 31, 2022 | -243,000.00 |
| Dec 31, 2021 | -275,000.00 |
| Sep 30, 2021 | -247,000.00 |
| Jun 30, 2021 | -237,000.00 |
| Mar 31, 2021 | -247,000.00 |